At a glance
ClinicalIndex Comparison RecordN/ACompleted· 150 enrolled
Drug / intervention
Iron sucrose +1 moredrug
Likely dose
Iron sucrose 100 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Multicenter, Randomized, Double-blind Comparison of Intravenous Iron Supplementation to Placebo for the Treatment of Anemia of Traumatic Critical Illness
In Brief
A clinical study evaluating Iron sucrose and Placebo for Trauma and ICU Anemia. Completed, enrolled 150 participants across 6 sites.
Detailed Summary
The purpose of this clinical trial is to determine whether intravenous iron supplementation of anemic, critically ill trauma patients improves anemia and reduces the need for a red blood cell transfusion.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsTrauma, ICU Anemia
CountriesUnited States
CollaboratorsNational Trauma Research Institute
Timeline
N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedAug 2010
Enrollment StartJun 2011
Primary CompletionSep 2013
TodayJul 2026
First PostedAug 12, 2010
Enrollment StartJun 1, 2011
Primary CompletionSep 1, 2013
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 15.9 years ago
Interventions
Iron sucrosedrug
100 mg IV TIW
Placebodrug